GPP-INTER LLC has acquired Trypylot, a neurotechnology startup specializing in wearables for cognitive wellness, to position itself as a leader in the $410 billion cognitive wellness market.
Target Information
GPP-INTER LLC is a strategic development and investment firm specializing in the acquisition and transformation of high-potential technology assets. Its primary focus is on advancing innovations that can reshape industries. The firm's flagship initiative is the acquisition of Trypylot, an emerging startup based in New Zealand that specializes in neurotechnology wearables. Trypylot has developed a unique device that measures brain activity (EEG) and heart rate variability (HRV), empowering users to manage their mental energy more effectively than ever before.
By acquiring Trypylot, GPP-INTER aims to leverage this groundbreaking technology to establish a global platform dedicated to cognitive wellness, positioning itself as the industry leader in mental performance enhancement.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in New Zealand
The neurotechnology sector has been gaining traction globally, with increasing recognition of the importance of mental wellness and cognitive enhancement. In New Zealand, there is a growing in
Similar Deals
Gannet BioChem → Laysan Bio
2026
GPP-INTER LLC
invested in
Trypylot
in 2025
in a Other deal